Extended data Table 3:
Clinical data for HIV patients
| EC | HIV dx | Sample date | CD4 at sample date | VL | HLA B57 | Sex | Race | HIV risk factor |
|---|---|---|---|---|---|---|---|---|
| 3 | 1991 | 10/12/012 | 1140 | 334 | − | M | AA | IDU |
| 4 | 1993 | 22/08/2011 | 952 | <40 | + | F | AA | HS |
| 6 | 1992 | 31/05/2011 | 1889 | <75 | + | F | AA | IDU |
| 8 | 1989 | 01/02/2010 | 1018 | <40 | + | M | AA | IDU |
| 9 | 2003 | 25/09/2014 | 496 | <40 | + | M | AA | IDU |
| 11 | 1997 | 10/72/011 | 917 | <40 | + | M | AA | IDU |
| 13 | 1993 | 21/02/2012 | 864 | <40 | − | M | AA | IDU |
| 31 | 1992 | 23/05/2012 | 587 | <48 | − | M | AA | MSM |
| 32 | 2000 | 23/05/2012 | 643 | <48 | − | F | AA | IDU |
| 42 | 1990 | 13/11/2013 | 731 | <220 | + | M | AA | IDU |
| 47 | 2007 | 01/12/2013 | 891 | <20 | − | F | AA | IDU |
| 51 | 2007 | 20/10/2014 | 1250 | <40 | + | F | AA | HS |
| 52 | 1992 | 01/08/2012 | 340 | <20 | + | M | AA | IDU |
| 55 | 1994 | 01/02/2013 | 482 | 50 | − | M | AA | IDU |
| 58 | 1991 | 01/03/2013 | 1745 | 59 | − | F | AA | HS |
| 63 | 1988 | 24/01/2014 | 632 | 32 | + | F | AA | IDU |
| 65 | 1991 | 01/06/2013 | 1792 | <48 | + | M | AA | HS |
| 68 | 2002 | 01/07/2010 | 584 | 169 | + | F | AA | HS |
| Untreated patients study_ID | sample date | CD4 at sample date | VL | Origin |
|---|---|---|---|---|
| 1 | 03/11/2004 | 506 | 23808 | NIH (Bethesda) |
| 2 | 22/04/2004 | 516 | 58059 | |
| 3 | 01/10/2005 | 230 | 153719 | |
| 4 | 27/09/2005 | 327 | 132773 | |
| 5 | 19/06/2006 | 419 | 1715 | |
| 6 | 04/10/2007 | 513 | 12015 | |
| 7 | 13/08/2007 | 447 | 21701 | |
| 8 | 13/03/2008 | 319 | 4785 | |
| 9 | 05/11/2011 | 756 | 7011 | |
| SS_20 | 08/10/2005 | 445 | 407 | |
| SS_21 | 11/10/2009 | 292 | 3012 | |
| SS_22 | 10/07/2010 | 477 | 29257 | |
| SS_23 | 07/22/08 | 639 | <50 | |
| SS_24 | 11/17/2008 | 267 | 26059 | |
| SS_25 | 03/23/2006 | 470 | 5384 | |
| SS_26 | 11/07/2012 | 740 | 11417 | |
| SS_27 | 01/28/2014 | 344 | 63954 | |
| SS_28 | 11/04/2010 | 872 | 7180 | |
| SS_29 | 12/03/2002 | 196 | 17809 | |
| AZT70934 | 12/03/2021 | 470 | 2480 | Laboratoire de Référence SIDA (Liège) |
| AZT71312=1373 | 12/03/2021 | 100 | 24800 | |
| AZT_71320_AFCHM_6 | 12/08/2020 | 139 | 32800 | |
| AZT_71333_KWGIF_7 | 12/09/2021 | 356 | 9790 | |
| AZT_71374_DIAMM_8 | 390 | 588000 | ||
| AZT_71391_GAFUM_9 | 02/24/2021 | 1064 | 14700 | |
| AZT71422 | 03/05/2021 | 30 | 850000 | |
| AZT_72336_GEMAM_11 | 20 | 824 | ||
| AZT_72498_YOLEF_12 | 280 | 82700 | ||
| AZT_72607_CHUIN | 03/16/2021 | 577 | 157000 | |
| AZT_72644_NGNNF | 03/18/2021 | 180 | 73700 | |
| AZT_76144 | 01/21/2022 | 321 | 122000 | |
| AZT_76469 | 02/18/2022 | 489 | 40000 | |
| AZT_76532 | 02/24/2022 | 449 | 1420000 | |
| AZT_7525 | 12/16/2021 | 405 | 49800 | |
| AZT_75872 | 12/30/2021 | 260 | 80900 | |
| AZT_74040 | 0719/2021 | 739 | 20300 |
| Treated patients study ID | sample date | CD4 at sample date | VL | Origin |
|---|---|---|---|---|
| 13 | 02/10/2017 | 685 | <40 | NIH (Bethesda) |
| 12 | 1/19/2017 | 912 | <40 | |
| 15 | 11/27/2017 | NA | na | |
| 11 | 12/08/2016 | 744 | <40 | |
| 17 | 7/19/2018 | NA | <40 | |
| 16 | 4/13/2018 | NA | <40 | |
| 18 | 9/26/2018 | NA | <40 | |
| 10 | 03/07/2012 | 417 | <40 | |
| 14 | 3/27/2017 | 809 | <40 | |
| SS_30 | 08/10/2006 | 503 | <50 | |
| SS_31 | 05/09/2012 | 402 | <50 | |
| SS_32 | 04/02/2013 | 627 | <40 | |
| SS_33 | 04/30/2010 | 603 | <50 | |
| SS_34 | 08/25/2010 | 404 | <50 | |
| SS_35 | 10/15/10 | 459 | <50 | |
| SS_36 | 10/21/2014 | 1328 | <40 | |
| SS_37 | 05/13/2016 | 410 | <40 | |
| SS_38 | 08/06/2010 | 682 | <40 | |
| SS_39 | 08/19/2004 | 437 | <50 | |
| AZT_72855_1 | 04/12/2021 | 245,6 | <20 | Laboratoire de Référence SIDA (Liège) |
| AZT_72856_2 | 04/12/2021 | 0 | <20 | |
| AZT_72979_3 | 04/21/2021 | 31,65 | <20 | |
| AZT_70944 | 10/27/2020 | 869 | <20 | |
| AZT_73954 | 07/13/2021 | 1016 | <20 | |
| AZT_73955 | 07/13/2021 | 788 | <20 | |
| AZT_73989 | 07/14/2021 | 960 | <20 | |
| AZT_74100 | 08/28/2021 | 1530 | <20 |